Because of margin and market growth pressures, life sciences supply chains are more dynamic than ever before. In 2009, best practice companies will continue to put in place data analysis processes and "human knowledge" collection procedures to spot red flags and safety risks in their end-to-end supply chains.

The way companies manage global trade and supply chain networks is changing. Aberdeen's research shows that leading performers are moving towards an integrated view of global trade management, focusing on simultaneously optimizing physical, financial and information flows and networks in order to achieve competitive advantage.